Zonisade Suspension
Product Images NDC 52652-8001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zonisade (NDC 52652-8001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label-061722 (Zonisamide Oral Suspension Carton Label)

Carton-label-061722 (Zonisamide Oral Suspension Carton Label)
This is a medication called ZONISADE™, which comes in a 150 mL bottle as an oral suspension containing 100 mg/5mL of the active ingredient onisanie (zonisamide). The recommended dosage is not provided, and the document advises to keep all medications out of the reach of children. Additionally, it provides storage instructions, suggests shaking well before use, and includes a note to pharmacists about dispensing medication guides for patients. The medication is made by Aautty Pramaceutical, Inc. in Wilmington, MA, USA, and the bottle label also includes a logo for azurity®.*
FDA Label Image

Chemical Structure (Zonisamide Oral Suspension Chemical Stucture)

FDA Label Image

Container-label-061722 (Zonisamide Oral Suspension Container Label)

Container-label-061722 (Zonisamide Oral Suspension Container Label)
Zonisade™ is an oral suspension medication which contains 20mg of zonisamide per mL. The recommended dosage should be obtained from the prescribing information. Zonisade™ should be kept out of reach of children and stored between 20°C and 25°C. Once opened, any unused portion should be discarded after 30 days. A medication guide is available at zonisade.com/medication-guide.pdf. This medication is manufactured in the United Kingdom for Azurity® in Wilmington, USA. The lot number and expiration date are provided, and a dispensing label should be affixed.*
FDA Label Image

Figure 1 (Zonisamide Oral Suspension Figure 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.